Table 1.
Human cells and cell lines used for assessment of GPCR expression.
Type of cancer | Cells or cell lines used | Source of cells or cell lines |
---|---|---|
B-cell chronic lymphocytic leukemia (CLL) | Patient-derived primary cells Normal human B cells | UCSD Moores Cancer Ctr |
Bone marrow stromal natural killer (NK) cells that support CLL cell growth | NK cells immortalized with telomerase reverse transcriptase | UCSD Moores Cancer Ctr |
Colon cancer | T-84, Caco-2 cell lines | ATCC |
Triple-negative breast cancer | BT-20, HS-578, MDA-MB-157, MDA-MB-436 cell lines | ATCC |
Pancreatic ductal adenocarcinoma | 34E/79E patient-derived cells (PDAC) cells and PDAC tumors Human control pancreatic ductal epithelial cells AsPC-1, MiaPaCa-2 cell lines | UCSD Moores Cancer Ctr. ATCC |
Pancreatic ductal adenocarcinoma | 5 primary patient-derived CAFs Human PSCs: Corresponding “normal” precursor cells | Lowy lab, UCSD Moores Cancer Ctr ScienCell Research Laboratories (#3830; ScienCell Research Laboratories, Carlsbad, CA, United States) |